Latest News>Infliximab biosimilar update

Infliximab biosimilar update

Infliximab biosimilar update

Are you on infliximab (Remicade®) for rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis?

If so, you should be aware that a new biosimilar brand of infliximab is now available on the Pharmaceutical Benefits Scheme (PBS).

This version is marketed under the brand name Inflectra®

It is important that you and your rheumatologist make an informed decision about which brand of infliximab you should receive (Remicade® or Inflectra®) and whether it is appropriate for you to switch from one brand to another. Talk to your rheumatologist to discuss which brand is right for you. Further information can be found on the factsheet provided by Arthritis Australia.

Your gift will help fund self-management courses, education seminars and will provide individual support for people living with arthritis.